Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma

S. K. Kumar; E. Ma; A. E. Engebretson; F. K. Buadi; M. Q. Lacy; A. Dispenzieri; M. S. Duh; M. H. Lafeuille; P. Lefebvre; W. Y. Cheng; K. Dea; D. Rembert; D. Patt; L. Niculescu; M. Quick; S. V. Rajkumar

doi:10.1038/leu.2015.225

Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma

S. K. Kumar, E. Ma, A. E. Engebretson, F. K. Buadi, M. Q. Lacy, A. Dispenzieri, M. S. Duh, M. H. Lafeuille, P. Lefebvre, W. Y. Cheng, K. Dea, D. Rembert, D. Patt, L. Niculescu, M. Quick, S. V. Rajkumar

Hematology

Research output: Contribution to journal › Letter › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	995-998
Number of pages	4
Journal	Leukemia
Volume	30
Issue number	4
DOIs	https://doi.org/10.1038/leu.2015.225
State	Published - Apr 1 2016

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/leu.2015.225

Cite this

Kumar, S. K., Ma, E., Engebretson, A. E., Buadi, F. K., Lacy, M. Q., Dispenzieri, A., Duh, M. S., Lafeuille, M. H., Lefebvre, P., Cheng, W. Y., Dea, K., Rembert, D., Patt, D., Niculescu, L., Quick, M., & Rajkumar, S. V. (2016). Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma. Leukemia, 30(4), 995-998. https://doi.org/10.1038/leu.2015.225

Kumar, SK, Ma, E, Engebretson, AE, Buadi, FK, Lacy, MQ , Dispenzieri, A, Duh, MS, Lafeuille, MH, Lefebvre, P, Cheng, WY, Dea, K, Rembert, D, Patt, D, Niculescu, L, Quick, M & Rajkumar, SV 2016, 'Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma', Leukemia, vol. 30, no. 4, pp. 995-998. https://doi.org/10.1038/leu.2015.225

@article{290c2aa7e07242c8bac4da7724c9a60a,

title = "Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma",

author = "Kumar, {S. K.} and E. Ma and Engebretson, {A. E.} and Buadi, {F. K.} and Lacy, {M. Q.} and A. Dispenzieri and Duh, {M. S.} and Lafeuille, {M. H.} and P. Lefebvre and Cheng, {W. Y.} and K. Dea and D. Rembert and D. Patt and L. Niculescu and M. Quick and Rajkumar, {S. V.}",

year = "2016",

month = apr,

day = "1",

doi = "10.1038/leu.2015.225",

language = "English (US)",

volume = "30",

pages = "995--998",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma

AU - Kumar, S. K.

AU - Ma, E.

AU - Engebretson, A. E.

AU - Buadi, F. K.

AU - Lacy, M. Q.

AU - Dispenzieri, A.

AU - Duh, M. S.

AU - Lafeuille, M. H.

AU - Lefebvre, P.

AU - Cheng, W. Y.

AU - Dea, K.

AU - Rembert, D.

AU - Patt, D.

AU - Niculescu, L.

AU - Quick, M.

AU - Rajkumar, S. V.

PY - 2016/4/1

Y1 - 2016/4/1

UR - http://www.scopus.com/inward/record.url?scp=84940731973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940731973&partnerID=8YFLogxK

U2 - 10.1038/leu.2015.225

DO - 10.1038/leu.2015.225

M3 - Letter

C2 - 26271606

AN - SCOPUS:84940731973

SN - 0887-6924

VL - 30

SP - 995

EP - 998

JO - Leukemia

JF - Leukemia

IS - 4

ER -

Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this